Repligen
RGEN
#2038
Rank
C$13.01 B
Marketcap
C$231.27
Share price
-0.46%
Change (1 day)
10.23%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.17 Billion

According to Repligen 's latest financial reports the company's total liabilities are C$1.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.22 B7.02%
2023-12-31C$1.14 B36.38%
2022-12-31C$0.84 B8.68%
2021-12-31C$0.77 B62.68%
2020-12-31C$0.47 B7.21%
2019-12-31C$0.44 B105.16%
2018-12-31C$0.21 B13.4%
2017-12-31C$0.19 B18.33%
2016-12-31C$0.16 B395.53%
2015-12-31C$32.58 M69.54%
2014-12-31C$19.21 M22.33%
2013-12-31C$15.71 M22.61%
2012-12-31C$12.81 M
2011-03-31C$5.04 M-5.5%
2010-03-31C$5.34 M-8.28%
2009-03-31C$5.82 M21.36%
2008-03-31C$4.8 M17.23%
2007-03-31C$4.09 M9.92%
2006-03-31C$3.72 M-7.46%
2005-03-31C$4.02 M25.64%
2004-03-31C$3.2 M-2.76%
2003-03-31C$3.29 M-22.55%
2002-03-31C$4.25 M114.49%
2001-03-31C$1.98 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
C$1.86 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.17 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.76 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$152.38 B 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$72.36 B 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$109.23 B 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$161.33 B 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.78 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.11 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$5.66 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA